CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers.
CRC-HUB-SPOKE:南加州社区健康中心的结肠直肠癌筛查中心。
基本信息
- 批准号:10251506
- 负责人:
- 金额:$ 84.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-19 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAdvisory CommitteesCaliforniaCaringCharacteristicsClinicColonoscopyColorectal CancerCountyDataData CollectionData SetDiagnosticEarly DiagnosisEducationEffectivenessElectronic Health RecordEnvironmentEvaluationEvidence based interventionGoalsHealthHealth TechnologyIncidenceIndividualInfrastructureInterventionInterviewMaintenanceMalignant NeoplasmsMeasuresMethodsModelingNavigation SystemNeighborhood Health CenterNonprofit OrganizationsOutcomePatientsPhasePreventive serviceProviderPublic Health InformaticsRuralSiteStandardizationSystemTest ResultTestingUnderserved PopulationWorkagedarmbasecolorectal cancer preventioncolorectal cancer screeningcostexperiencefollow-upimplementation strategyimprovedmortalityoutreachpatient orientedphase 2 studyrandomized trialscale upscreeningtreatment as usualuptake
项目摘要
ABSTRACT
Colorectal cancer (CRC) screening and appropriate follow-up can reduce incidence and mortality. The US
Preventive Services Task Force (USPSTF) recommends CRC screening through a variety of invasive and non-
invasive tests for individuals aged 50 to 75 years. Evidence-based interventions (EBIs) and other strategies
exist to promote CRC screening, but adoption and implementation of these are limited, especially in CHCs.
Our hypothesis is that a Hub and Spoke multilevel intervention will be superior to usual care. The hub will be
Health Quality Partners of Southern California (HQP), a non-profit organization comprised of 16 CHC systems
(spokes), serving 135 rural and urban clinic sites. We propose a 2-phase study to pilot and optimize (Phase I)
and rigorously test (Phase II) the Hub and Spoke approach and its impact on CRC screening, follow-up, and
usual care. UG3 Planning/Exploratory Phase AIM: Pilot test the feasibility, acceptability, and preliminary
outcomes of a multilevel intervention for CRC screening, follow-up, and referral-to-care using a mixed
methods approach. The intervention includes HQP hub-based delivery of centralized mailed FIT to patients
served by individual CHCs-spokes plus complimentary provider and clinic-level interventions at CHCs, and
coordination of a standardized navigation strategy delivered by CHCs for abnormal FIT follow-up. UH3
Implementation Phase. We will conduct a 2-arm pragmatic randomized trial to assess impact of a
regionally-developed multilevel intervention to increase CRC screening, follow-up, and referral-to-care
among CHC patients. The trial will be guided by the Pragmatic, Robust Implementation and Sustainability
Model (PRISM), which includes outcomes from the Reach, Effectiveness, Adoption, Implementation,
Maintenance (RE-AIM) framework and expands them with contextual constructs. Aim 1. Assess effectiveness
of the multilevel intervention based on: 1) improvement in proportion up-to-date with screening 3 years post
implementation; 2) proportion with abnormal FIT who complete diagnostic colonoscopy within 6 months; and 3)
proportion with CRC completing first treatment evaluation. Aim 2. Evaluate the implementation, scalability, and
sustainability of a multilevel implementation strategy. Implementation will be evaluated with a mixed methods
approach using the RE-AIM outcomes of Reach, Adoption, and Implementation as well as the PRISM
constructs of Intervention Characteristics and Recipients from perspective of multiple stakeholders (i.e.
patients, front-line staff, and operational leaders). We will also calculate replication costs. Scalability and
Sustainability will be evaluated using the RE-AIM outcome of Maintenance and the PRISM constructs of
Implementation & Sustainability Infrastructure and External Environment. Our study will help accelerate
progress in CRC prevention in underserved populations by identifying multilevel intervention strategies that are
scalable to additional CHCs in the region, with potential for larger scale implementation.
摘要
结直肠癌(CRC)筛查和适当的随访可以降低发病率和死亡率。美国
预防服务工作组(USPSTF)建议通过各种侵袭性和非侵入性
对年龄在50岁到75岁之间的人进行侵入性测试。循证干预(EBI)和其他战略
存在促进儿童权利委员会筛查的办法,但采用和实施这些办法受到限制,特别是在儿童保健中心。
我们的假设是,中心辐射式多层次干预将优于通常的护理。枢纽将是
南加州健康质量合作伙伴(HQP),一个由16个CHC系统组成的非营利性组织
(辐条),服务于135个农村和城市诊所站点。我们建议分两个阶段进行试验和优化(第一阶段)
并严格测试(第二阶段)中心辐射式方法及其对CRC筛查、后续和
照常照看。UG3规划/探索阶段目标:试行测试可行性、可接受性和初步
使用混合方案对结直肠癌筛查、随访和转诊至护理的多水平干预结果
方法:研究方法。干预措施包括基于HQP集线器的集中邮寄FIT给患者的交付
由个别社区卫生中心提供服务,外加免费提供者和诊所级别的干预服务,以及
协调CHC提供的标准化导航策略,以进行异常匹配跟踪。UH3
实施阶段。我们将进行一项双臂务实随机试验,以评估
区域制定的多层次干预措施,以增加结直肠癌筛查、随访和转诊至护理
在慢性丙型肝炎患者中。试验将以务实、稳健的实施和可持续发展为指导
模型(PRISM),其中包括REACH、有效性、采用、实施、
维护(RE-AIM)框架,并使用上下文构造对其进行扩展。目标1.评估有效性
多层次干预的基础是:1)在3年后进行筛查,改善了最新比例
实施;2)在6个月内完成诊断结肠镜检查的异常匹配比例;以及3)
完成首次治疗评估的患者比例。目标2.评估实施、可伸缩性和
多层次实施战略的可持续性。实施情况将采用混合方法进行评估
使用REACH、采用和实施以及PRISM的RE-AIM成果的方法
从多个利益相关者的角度构建干预特征和对象(即
患者、一线工作人员和运营领导)。我们还将计算复制成本。可扩展性和
将使用维护的RE-AIM结果和PRISM结构来评估可持续性
实施与可持续基础设施和外部环境。我们的研究将有助于加快
通过确定多层次干预策略,在服务不足的人群中预防结直肠癌的进展
可扩展到该地区更多的社区卫生中心,具有更大规模实施的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sheila Faye Castaneda其他文献
Sheila Faye Castaneda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sheila Faye Castaneda', 18)}}的其他基金
COVID-19 testing in Underserved and Vulnerable Populations Receiving Care in San Diego Community Health Centers
在圣地亚哥社区健康中心接受护理的服务不足和弱势群体中进行 COVID-19 检测
- 批准号:
10258699 - 财政年份:2020
- 资助金额:
$ 84.54万 - 项目类别:
CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers.
CRC-HUB-SPOKE:南加州社区健康中心的结肠直肠癌筛查中心。
- 批准号:
10264933 - 财政年份:2019
- 资助金额:
$ 84.54万 - 项目类别:
Project 2: A randomized trial of outreach and inreach strategies for boosting colorectal cancer screening in a Federally-Qualified Health Center primarily serving low income Hispanic/Latinos
项目 2:在主要为低收入西班牙裔/拉丁美洲人服务的联邦合格健康中心进行外展和内展策略的随机试验,以促进结直肠癌筛查
- 批准号:
9043696 - 财政年份:2008
- 资助金额:
$ 84.54万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 84.54万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 84.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 84.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 84.54万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 84.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 84.54万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 84.54万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 84.54万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 84.54万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 84.54万 - 项目类别:
Standard Grant














{{item.name}}会员




